Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension).

[1]  Mark D Twite,et al.  The Post-Anesthetic Care of Pediatric Patients With Pulmonary Hypertension , 2016, Seminars in cardiothoracic and vascular anesthesia.

[2]  P. Laussen,et al.  The Impact of Targeted Therapies for Pulmonary Hypertension on Pediatric Intraoperative Morbidity or Mortality , 2015, Anesthesia and analgesia.

[3]  I. Adatia,et al.  Cardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease , 2015, Pediatric Cardiology.

[4]  H. Hillege,et al.  Identification of treatment goals in paediatric pulmonary arterial hypertension , 2014, European Respiratory Journal.

[5]  H. Hillege,et al.  Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies. , 2014, Journal of the American College of Cardiology.

[6]  R. Friesen,et al.  The anesthetic management of children with pulmonary hypertension in the cardiac catheterization laboratory. , 2014, Anesthesiology clinics.

[7]  A. Cartón,et al.  Pulmonary hypertension in bronchopulmonary dysplasia: Clinical findings, cardiovascular anomalies and outcomes , 2014, Pediatric pulmonology.

[8]  T. Fleming,et al.  Pediatric pulmonary hypertension. , 2013, Journal of the American College of Cardiology.

[9]  Alejandro Torres,et al.  Safety of Cardiac Catheterization at a Center Specializing in the Care of Patients with Pulmonary Arterial Hypertension , 2013, Pulmonary circulation.

[10]  J. Feinstein,et al.  Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice , 2013, European Respiratory Journal.

[11]  G. Raskob,et al.  Clinical features of paediatric pulmonary hypertension: a registry study , 2012, The Lancet.

[12]  H. Hillege,et al.  Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. , 2011, European heart journal.

[13]  A. Günther,et al.  Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011. , 2011, International journal of cardiology.

[14]  R. Barst,et al.  Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management , 2011, Circulation.

[15]  J. Wild,et al.  ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre , 2011, European Respiratory Journal.

[16]  E. Bacha,et al.  Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. , 2011, Circulation.

[17]  K. Gauvreau,et al.  Procedure-Type Risk Categories for Pediatric and Congenital Cardiac Catheterization , 2011, Circulation. Cardiovascular interventions.

[18]  D. Ivy,et al.  Assessment of pulmonary hypertension in the pediatric catheterization laboratory: Current insights from the magic registry , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  R. Barst,et al.  Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. , 2010, The American journal of cardiology.

[20]  M. Mullen,et al.  Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it? , 2010, The Journal of pediatrics.

[21]  R. Barst,et al.  Vasodilator Testing with Nitric Oxide and/or Oxygen in Pediatric Pulmonary Hypertension , 2010, Pediatric Cardiology.

[22]  M. Almodovar,et al.  Anesthesia considerations for children with pulmonary hypertension. , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[23]  S. Bratton,et al.  Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine , 2010, Paediatric anaesthesia.

[24]  K. Gauvreau,et al.  Adverse event rates in congenital cardiac catheterization — A multi‐center experience , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[25]  A. McEwan,et al.  Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. , 2007, British journal of anaesthesia.

[26]  R. Friesen,et al.  Perioperative Complications in Children with Pulmonary Hypertension Undergoing Noncardiac Surgery or Cardiac Catheterization , 2007, Anesthesia and analgesia.

[27]  Z. Jing,et al.  Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. , 2006, Journal of the American College of Cardiology.

[28]  M. Humbert,et al.  Pulmonary arterial hypertension in France: results from a national registry. , 2006, American journal of respiratory and critical care medicine.

[29]  M. Humbert,et al.  Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.

[30]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[31]  C. Lafarge,et al.  The estimation of oxygen consumption. , 1970, Cardiovascular research.